• A Case of Neuroleptic Malignant Syndrome After COVID-19 Vaccination and Possible Mechanisms of Vaccines in the Formation of This Syndrome
• A Case of Neuroleptic Malignant Syndrome in the Context of Lithium Toxicity and Aripiprazole Use
• A Case of Neuroleptic Malignant Syndrome Presenting as Anxiety
• A fatal case of fulminant neuroleptic malignant syndrome: A case report
• A Rare Case of Malignant Syndrome in Parkinson's Disease Caused by Severe Dehydration and Complicated by Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
• A rare case of prochlorperazine-induced neuroleptic malignant syndrome
• A Series of Eight Cases of Pigment Nephropathy: An Obscured Aspect of Acute Kidney Injury
• Adolescent Aripiprazole-Associated Rhabdomyolysis Without Neuroleptic Malignant Syndrome: A Case Report
• An Atypical Case of Neuroleptic Malignant Syndrome Associated With Ciprofloxacin and Quetiapine
• An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders
• An Unusual Cause of Persistent Tachycardia: Atypical Neuroleptic Malignant Syndrome
• An Unusual Presentation of Serotonin Syndrome and Subsequent Catatonia in a Patient With a Family History of Huntington's Disease
• Anesthesia Management for Electroconvulsive Therapy
• Aripiprazole-induced quasi-neuroleptic malignant syndrome: two case reports
• ATYPICAL NEUROLEPTIC MALIGNANT SYNDROME ASSOCIATED WITH MIRTAZAPINE USE
• Atypical neuroleptic malignant syndrome in an incarcerated patient: a demographic who may be at increased risk
• Atypical Neuroleptic Malignant Syndrome With Type 2 Respiratory Failure Treated With Non-invasive Ventilation
• Atypical Presentation of Ziprasidone-Induced Neuroleptic Malignant Syndrome: A Case Report
• Bromocriptine
• Case report: Avoiding intolerance to antipsychotics through a personalized treatment approach based on pharmacogenetics
• Catatonia-related adverse outcomes after long-acting injectable antipsychotics: Case series
• Catatonia: A Narrative Review for Hospitalists
• Caution for psychiatrists: malignant hyperthermia risks with the anesthetic agent succinylcholine (Suxamethonium) during electroconvulsive therapy
• Central anticholinergic, neuroleptic malignant and serotonin syndromes
• Challenges in the Clinical Diagnosis of Lithium Toxicity: A Case Report
• Concomitant Administration of Ozanimod and Serotonergic Antidepressants in Patients With Ulcerative Colitis or Relapsing Multiple Sclerosis
• Concurrent administration of serotonergic antidepressants and ozanimod in participants with relapsing multiple sclerosis from the open-label extension DAYBREAK trial
• Cooling Techniques for Hyperthermia
• COVID-19 Pandemic-Delayed Diagnosis and Treatment of Atypical Neuroleptic Malignant Syndrome in a Violent Forensics Patient With Intellectual Disability and Treatment-Resistant Schizophrenia
• Development of Atypical Neuroleptic Malignant Syndrome After Treatment of Cocaine Intoxication: A Case Report and Literature Review
• Dopamine Agonists
• Electroconvulsive Therapy
• Electrolyte Disturbances Related to Sodium and Potassium and Electroconvulsive Therapy: A Systematic Review
• Elevated Creatine Phosphokinase in a Patient on a Long-Acting Antipsychotic: A Challenging Presentation Similar to Neuroleptic Malignant Syndrome
• EMS Methods to Cool a Patient in the Field
• Evaluation of neuroleptic malignant syndrome induced by antipsychotic drugs using spontaneous reporting system
• Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology
• Examining the Features of Neuroleptic Malignant Syndrome in Anti-NMDA Receptor Encephalitis: A Case-Control Study
• First generation antipsychotic-associated serious adverse events in women: a retrospective analysis of a pharmacovigilance database
• Functional propriospinal myoclonus in neuroleptic malignant syndrome
• Haloperidol-Induced Neuroleptic Malignant Syndrome: A Case Report
• Hold off That Olanzapine! The Development of Neuroleptic Malignant Syndrome in a Dehydrated Pediatric Patient
• Infectious disease evaluations in a psychiatric unit, an observational study
• Integrating Physiotherapy in Neuroleptic Malignant Syndrome Management: A Case Report
• Long prodromal symptoms of neuroleptic malignant syndrome in patient with intellectual developmental disorder-A case report
• Loxapine in the Treatment of Manic and Psychotic Symptoms in an Individual Intolerant to Multiple Mood-Stabilizing and Antipsychotic Medications
• Malignant psoas syndrome and bilateral hydronephrosis without evident obstruction in colorectal cancer
• Malignant Tourette's Syndrome in an Adult on Deep Brain Stimulation Presenting With Rhabdomyolysis
• Mixed Connective Tissue Disease Presenting With Psychosis-A Case Report
• Neuroleptic Intolerance and Residual Mutism in a Young Woman with Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis
• Neuroleptic malignant syndrome
• Neuroleptic Malignant Syndrome
• Neuroleptic malignant syndrome after abrupt discontinuation of neuroleptic and anticholinergic drugs
• Neuroleptic Malignant Syndrome After Lithium Withdrawal
• Neuroleptic malignant syndrome after overdose of haloperidol - A case report
• Neuroleptic malignant syndrome and serotonin syndrome: a comparative bibliometric analysis
• Neuroleptic malignant syndrome associated with atypical antipsychotics: A case report
• Neuroleptic Malignant Syndrome Associated With Lurasidone: A Case Report
• Neuroleptic Malignant Syndrome Associated With Lurasidone: A Case Report
• Neuroleptic Malignant Syndrome Concurrent with COVID-19 Infection: A Case Report
• Neuroleptic malignant syndrome following clozapine withdrawal
• Neuroleptic Malignant Syndrome Improved with Intramuscular Administration of the Anticholinergic Agent, Biperiden
• Neuroleptic Malignant Syndrome in a 15-Month-Old Child: A Case Report
• Neuroleptic Malignant Syndrome in a 15-Month-Old Child: A Case Report
• Neuroleptic Malignant Syndrome in Patients With Dementia: Experiences of A Single Memory Clinic
• Neuroleptic Malignant Syndrome in Patients With Dementia: Experiences of A Single Memory Clinic
• Neuroleptic malignant syndrome induced by aripiprazole depot
• Neuroleptic Malignant Syndrome Status Post Anoxic Brain Injury: A Case Presentation of Heightened Susceptibility in the Brain Injury Population
• Neuroleptic Malignant Syndrome with Underlying Catatonia - a Case Report
• Neuroleptic Malignant Syndrome: An Intensive Care Unit Case of Exceptionally High Creatinine Kinase and Myoglobin Levels
• Neuroprotective effects of dantrolene in neurodegenerative disease: Role of inhibition of pathological inflammation
• Non-Psychosis Symptoms of Clozapine Withdrawal: a Systematic Review
• Parkinsonism-Hyperpyrexia Syndrome in a patient undergoing upper gastrointestinal surgery: A case report
• Parkinsonism-hyperpyrexia, a rare consequence of deep brain stimulator malfunction in advanced Parkinson's disease
• Pharmacological Considerations of Neuroleptic Malignant Syndrome in a Patient on a Long-Acting Antipsychotic
• Postoperative rhabdomyolysis due to neuroleptic malignant syndrome associated with droperidol and metoclopramide
• Prochlorperazine-induced neuroleptic malignant syndrome
• Rapid symptom control in neuroleptic malignant syndrome with electroconvulsive therapy: A case report
• Rebound Catatonia Associated With Injectable Paliperidone
• Recurrent Fevers, Dysautonomia, and Dehydration in a Patient With Lesch-Nyhan Syndrome
• Reintroduction of Clozapine following Neuroleptic Malignant Syndrome in a Young Patient with Resistant Schizophrenia
• Serious adverse drug events associated with psychotropic treatment of bipolar or schizoaffective disorder: a 17-year follow-up on the LiSIE retrospective cohort study
• Serotonin syndrome and neuroleptic malignant syndrome: A case report of intersecting symptomatology
• Serotonin syndrome caused by a CYP2C19-mediated interaction between low-dose escitalopram and clopidogrel: a case report
• Serotonin Syndrome: The Role of Pharmacology in Understanding Its Occurrence
• Severe Recurrence of Neuroleptic Malignant Syndrome: Usefulness of Dexmedetomidine for Antipsychotic Withdrawal
• Subthalamic Deep Brain Stimulation in Parkinson's Disease: A Boon or Bane - A Single Centre Retrospective Observational Study from India
• Successful Diagnosis of Neuroleptic Malignant Syndrome in an Unconscious Patient Using Amplitude-Integrated Electroencephalography: A Case Report
• Successful Treatment of Both Refractory Neuroleptic Malignant Syndrome and Subsequent Catatonia With Electroconvulsive Therapy in a Patient With Suspected Kufs Disease
• Syndrome malin des neuroleptiques
• The akinetic crisis in Parkinson´s disease- the upper end of a spectrum of subacute akinetic states
• The Atypical Face of Neuroleptic Malignant Syndrome: A Case Report of Ileus and Absent Rigidity
• The diagnosis and treatment of catatonia
• The diagnosis and treatment of catatonia
• The diagnostic dilemma in a patient with neuroleptic malignant syndrome during the COVID-19 pandemic: A significant increase in acute phase reactants
• The role of antipsychotics and other drugs on the development and progression of neuroleptic malignant syndrome
• Transient Fever Response After ECT in a Patient with Catatonic Schizophrenia: A Case Report
• Use of En-Bloc Multiple Monitored Electroconvulsive Therapy in Benzodiazepine Refractory Malignant Catatonia
• What clinical analysis of antipsychotic-induced catatonia and neuroleptic malignant syndrome tells us about the links between these two syndromes: A systematic review
• When the fever will not stop, stop the pills! A case report